TY - JOUR KW - Models, Molecular KW - Animals KW - Structure-Activity Relationship KW - Oligopeptides KW - Molecular Structure KW - Peptide Fragments KW - Magnetic Resonance Spectroscopy KW - Amyloid beta-Peptides KW - Protein Multimerization KW - Biological Products KW - Cell Survival KW - Cells, Cultured KW - Dose-Response Relationship, Drug KW - Drosophila melanogaster KW - Female KW - PC12 Cells KW - Protein Stability KW - Rats AU - A. Frydman-Marom AU - M. Convertino AU - R. Pellarin AU - A. Lampel AU - R. Shaltiel-Karyo AU - D. Segal AU - A. Caflisch AU - D. E. Shalev AU - E. Gazit AB -

The distribution of endomorphins (EM) 1 and 2 in the human brain inversely correlates with cerebral neurodegeneration in Alzheimer's disease (AD), implying a protective role. These endogenous opioid peptides incorporate aromatic residues and a β-breaker motif, as seen in several optimized inhibitors of Aβ aggregation. The activity of native endomorphins was studied, as well as the rationally designed analogue Aib-1, which includes a remarkably efficient β-breaker, α-aminoisobutyric acid (Aib). In vitro and GFP fusion protein assays showed that Aib-1 interacted with Aβ and markedly inhibited the formation of toxic oligomer and fibril growth. Moreover, Aib-1 prevented the toxicity of Aβ toward neuronal PC12 cells and markedly rectified reduced longevity of an AD fly model. Atomistic simulations and NMR-derived solution structures revealed that Aib-1 significantly reduced the propensity of Aβ to aggregate due to multimode interactions including aromatic, hydrophobic, and polar contacts. We suggest that hindering the self-assembly process by interfering with the aromatic core of amyloidogenic peptides may pave the way toward developing therapeutic agents to treat amyloid-associated diseases.

BT - ACS Chemical Biology C1 - 0150 DA - 2011 Nov 18 DO - 10.1021/cb200103h IS - 11 J2 - ACS Chem. Biol. LA - eng M3 - Research Article N2 -

The distribution of endomorphins (EM) 1 and 2 in the human brain inversely correlates with cerebral neurodegeneration in Alzheimer's disease (AD), implying a protective role. These endogenous opioid peptides incorporate aromatic residues and a β-breaker motif, as seen in several optimized inhibitors of Aβ aggregation. The activity of native endomorphins was studied, as well as the rationally designed analogue Aib-1, which includes a remarkably efficient β-breaker, α-aminoisobutyric acid (Aib). In vitro and GFP fusion protein assays showed that Aib-1 interacted with Aβ and markedly inhibited the formation of toxic oligomer and fibril growth. Moreover, Aib-1 prevented the toxicity of Aβ toward neuronal PC12 cells and markedly rectified reduced longevity of an AD fly model. Atomistic simulations and NMR-derived solution structures revealed that Aib-1 significantly reduced the propensity of Aβ to aggregate due to multimode interactions including aromatic, hydrophobic, and polar contacts. We suggest that hindering the self-assembly process by interfering with the aromatic core of amyloidogenic peptides may pave the way toward developing therapeutic agents to treat amyloid-associated diseases.

PY - 2011 SP - 1265 EP - 1276 T2 - ACS Chemical Biology TI - Structural basis for inhibiting β-amyloid oligomerization by a non-coded β-breaker-substituted endomorphin analogue VL - 6 SN - 1554-8937 ER -